Skip to content

BioSig Technologies, Inc. STEX Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
Bit Digital logo
Bit DigitalBTBT
TEC
Bio-TechneTECH
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-56.4%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s deferred tax assets and other non-current assets?
BioSig Technologies, Inc. (STEX) reported deferred tax assets and other non-current assets of $15.23M in Q1 2026.
How has BioSig Technologies, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
BioSig Technologies, Inc.'s deferred tax assets and other non-current assets increased by 34502.3% year-over-year, from $44K to $15.23M.
What is the long-term trend for BioSig Technologies, Inc.'s deferred tax assets and other non-current assets?
Over 4 years (2020 to 2024), BioSig Technologies, Inc.'s deferred tax assets and other non-current assets has grown at a -13.7% compound annual growth rate (CAGR), from $453.49K to $252K.